Home/Pipeline/ZM-007

ZM-007

Canine Lymphoma

Pre-clinicalDevelopment Paused

Key Facts

Indication
Canine Lymphoma
Phase
Pre-clinical
Status
Development Paused
Company

About Zomedica Pharmaceuticals

Zomedica Pharmaceuticals is a veterinary diagnostics and therapeutics company dedicated to advancing companion animal health. Its primary commercial asset is the TRUFORMA® platform, a point-of-care biosensor that enables veterinarians to perform rapid, in-clinic diagnostic testing. The company has transitioned from a development-stage entity to a commercial organization, focusing on expanding its assay menu and driving adoption within veterinary clinics. Zomedica's strategy involves leveraging its platform technology to address significant unmet needs in veterinary endocrinology and other disease areas.

View full company profile